ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2015
Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD : 4. Novel applications of cardiovascular PET.
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.
- Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic Review.Transplantation · 2017Pooled it
- Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017Article
- Expanding the Horizons of Nuclear Cardiology: Disease Management.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While it is well recognized that cardiac PET has the ability to accurately detect myocardial ischemia and coronary blood flow, there are multiple other novel and clinically important cardiac applications of PET which are now available for the evaluation of various disease processes of the cardiovascular system. Many of these applications utilize F18-fluorodeoxyglucose (FDG), a glucose analog which is retained within cells with a high metabolic activity and which has been used extensively in nuclear medicine to evaluate oncology patients and has recently also been used to evaluate infections. This review provides an overview of some of the clinically available novel applications, Figure 1, in cardiac PET which were discussed at the American Society of Nuclear Cardiology Cardiac PET Summit, May 12, 2014. Figure 1 Novel applications of cardiac PET.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.